Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-008049
Filing Date
2013-02-13
Accepted
2013-02-13 11:30:32
Documents
1
Period of Report
2012-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v334814_form4.html 4  
1 OWNERSHIP DOCUMENT v334814_form4.xml 4 8635
  Complete submission text file 0001144204-13-008049.txt   10877
Mailing Address TOWER 56, SUITE 700, 126 E. 56TH STREET 7TH FLOOR NEW YORK NY 10022
Business Address TOWER 56, SUITE 700, 126 E. 56TH STREET 7TH FLOOR NEW YORK NY 10022 212-909-4600
Vicis Capital, LLC (Reporting) CIK: 0001341950 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-52369 | Film No.: 13600767

Mailing Address 126 EAST 56TH STREET TOWER 56, SUITE 700 NEW YORK NY 10022
Business Address 126 EAST 56TH STREET TOWER 56, SUITE 700 NEW YORK NY 10022 212-909-4600
Vicis Capital Master Fund (Reporting) CIK: 0001365954 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-52369 | Film No.: 13600766

Mailing Address 11011 Q STREET BUILDING A SUITE 106 OMAHA NE 68137
Business Address 11011 Q STREET BUILDING A SUITE 106 OMAHA NE 68137 402-884-1894
BOND LABORATORIES, INC. (Issuer) CIK: 0001374328 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products